A Naturalistic Controlled Trial of Individual Placement and Control in Bodø
NCT ID: NCT04179877
Last Updated: 2019-11-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
77000 participants
INTERVENTIONAL
2013-01-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. employment,
2. welfare dependency, and
3. public-sector health care utilization.
This is a naturalistic controlled trial, where one municipality (Bodø in Norway) with about 50000 inhabitants get access to IPS services in public sector mental health services during the period 2013-2016. The target group for the intervention is patients with severe mental illness (SMI) in the age group 18-40 at time of treatment. Patients already receiving lifelong disability benefits will be excluded.
The control group will be an average of 10 municipalities in Norway without IPS services.
Data for outcomes will be based on public registries available for research.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Work Outcome for People With Severe Mental Illness
NCT01722344
Wellbeing and Resilience Among 1-3 Years Old Children of Mothers with Complex Mental Health Problems: a Pragmatic Clinical Trial of Online VIPP-SD Vs. Care As Usual
NCT06795347
Behavioral Activation - From Inpatient to Outpatient Services
NCT01786733
Critical Time Intervention-Peer Support
NCT05945277
Independent Housing and Support for People With Severe Mental Illness
NCT03815604
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. increasing employment,
2. reducing welfare dependency, and
3. reducing public-sector health care utilization.
This is a naturalistic controlled trial, where one municipality (Bodø in Norway) with about 50000 inhabitants get access to IPS services in public sector mental health services during the period 2013-2016. The follow-up period will last until 2022. The target group for the intervention is patients with severe mental illness (SMI) in the age group 18-40 at time of treatment, with an ambition of 200 received IPS services. The investigators aim to study the effectiveness on the societal (not individual) level, assuming spill-over effects within Bodø municipality as a result of system changes in the treatment municipality (Bodø). Patients already receiving lifelong disability benefits will be excluded. The control group will be 10 similar municipalities in Norway without IPS services and will be chosen on the basis of similarities in economy, demography and geography and collected from publicly available information. Approximately 77000 subjects will be enrolled in this study; 7000 subjects from Bodø municipality and 70000 from the other 10 municipalities (the control group).
Data for outcomes will be based on public registries available for research. Outcome operationalizations are:
1. Employment will be based on registry data from tax records with information both on employment (yes/no and period) and taxable income (NOK).
2. Welfare dependency will be based on registry data including rehabilitation benefits, disability benefits, sickness absence, unemployment benefits, and social benefits. These will be analysed separate and combined, and the main hypothesis will be based on the latter.
3. Health care utilization will be based on data from the Norwegian Patient Register. Data for in-patient and out-patients treatments for mental illness and other (separate analyses) will be used. These will be analysed separate and combined, and the main hypothesis will be based on the first.
The data will be analyzed in two rounds; first in 2019, and a follow-up analysis in 2022. A difference-in-difference approach will be used to measure the effects.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individual placement and support
Group of patients receiving IPS to increase workforce participation.
IPS
Occupational rehabilitation and support Integrated with clinical treatment
Control
Group of patients receiving treatment as usual.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IPS
Occupational rehabilitation and support Integrated with clinical treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Work assessment allowance
Exclusion Criteria
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nordlandssykehuset HF
OTHER
University of Tromso
OTHER
London School of Economics and Political Science
OTHER
University of Melbourne
OTHER
St George's Healthcare NHS Trust
OTHER
The University of New South Wales
OTHER
Norwegian Institute of Public Health
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnstein Mykletun, Prof PsyD
Role: PRINCIPAL_INVESTIGATOR
Norwegian IPH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nordland Hospital Trust
Bodø, Nordland, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IPSBODO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.